The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Anxiety and Mounjaro — Understanding the Comparison
If you're considering Mounjaro or Wegovy for weight management and have concerns about anxiety, it's important to understand how these prescription-only medications differ and what clinical evidence shows about mental health side effects. Both tirzepatide (Mounjaro) and semaglutide (Wegovy) are GLP-1-based weight loss injections available in the UK following clinical assessment, but they work through different mechanisms. This guide compares both medications specifically regarding anxiety concerns, using clinical trial data and NHS-aligned information to help you have an informed conversation with your GP or prescriber.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro vs Wegovy — Mechanism Differences and Mental Health Context
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, meaning it activates two natural hormone pathways simultaneously. Wegovy (semaglutide) is a GLP-1 agonist only, activating a single pathway. This mechanistic difference is important when considering anxiety risk, as GLP-1 activation affects appetite regulation, gastric emptying, and potentially mood-related neurotransmitter systems.
In the SURMOUNT-1 clinical trial for Mounjaro, anxiety was reported in less than 1% of participants taking the 15 mg dose. The STEP-1 trial for Wegovy (2.4 mg) similarly reported anxiety in a small percentage of participants. Both medications showed comparable mental health safety profiles in their primary weight management trials. However, individual responses vary significantly — some people experience no anxiety changes, whilst others report mood improvements alongside weight loss, likely due to improved physical health and confidence.
Both medications require a prescription and clinical assessment to determine suitability. Your prescriber will review your personal medical history, including any existing anxiety or mental health conditions, before recommending either medication.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Individual Suitability — Which Is Right for You?
The choice between Mounjaro and Wegovy depends on your individual health profile, not on anxiety risk alone, since both show similar mental health safety in clinical trials. Mounjaro's dual mechanism may appeal if you want a single injection option with potentially greater appetite suppression, but requires careful monitoring if you have a history of anxiety, as the dual hormone activation is newer. Wegovy's single GLP-1 mechanism has longer clinical use history and may feel more familiar to prescribers managing anxiety-prone patients, though efficacy is comparable.
Regardless of which medication you're prescribed, report any changes in mood, anxiety, or mental health to your GP immediately. These medications are typically prescribed alongside lifestyle changes — reduced-calorie diet and increased physical activity — which themselves improve mental health outcomes. Use our free GLP-1 weight loss calculator to explore projected outcomes at different doses, and track your overall progress and mood changes with our progress tracker to share with your healthcare provider.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can Mounjaro or Wegovy cause anxiety in the UK?
Both medications show low reported anxiety rates in clinical trials (under 1% in primary studies). However, anxiety can occur as a side effect in some individuals. Any pre-existing anxiety disorders should be discussed with your prescriber before starting either medication, as personalised monitoring may be needed.
Is Mounjaro or Wegovy better for people with anxiety?
There is no clinical evidence that one is superior to the other for anxiety management. Both require individual assessment by your GP or prescriber. If you have existing anxiety, your prescriber may recommend the medication with the longest safety record for your specific situation.
What's the difference between Mounjaro's tirzepatide and Wegovy's semaglutide?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 agonist activating two hormone pathways. Wegovy (semaglutide) is a GLP-1 agonist only. This mechanistic difference may affect appetite suppression and potentially mood, but both show comparable mental health safety in trials.
Should I avoid GLP-1 weight loss injections if I have anxiety?
Not necessarily. Many people with anxiety successfully use these medications. The key is discussing your full medical history, including anxiety disorders, with your prescriber before treatment. They'll assess whether either medication is suitable and provide appropriate monitoring throughout your treatment.
How quickly might anxiety symptoms appear with Mounjaro or Wegovy?
If anxiety occurs, it typically appears within the first few weeks of starting treatment or after a dose increase (dose titration). Report any new anxiety symptoms to your GP or prescriber immediately. Weight loss itself often improves mental health over time, offsetting initial side effects.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.